SPROSpero Therapeutics, Inc.同业对比
Spero Therapeutics, Inc. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SPRO本股 | $70M#8 | 8.6x#1 | 1.6x#6 | 5.6x#1 | 3292.5%#1 | 112.5%#1 | 50.2%#1 | 19.4%#3 | — | — | -41.5%#11 | — |
| TELO | $77M#1 | — | 15.4x#13 | — | — | 37.0%#2 | — | -206.9%#11 | — | — | -6.6%#5 | — |
| VBIO | $76M#2 | — | 18.0x#14 | 97.7x#3 | -33.7%#2 | -57.0%#12 | -1012.6%#2 | -209.1%#12 | — | — | -95.6%#16 | — |
| OSTX | $76M#3 | — | — | — | — | -223.7%#16 | — | — | — | — | -25.7%#8 | — |
| CING | $74M#4 | — | 3.1x#10 | — | — | -35.6%#11 | — | -95.7%#9 | — | — | 35.6%#2 | — |
| CALC | $73M#5 | — | 13.2x#12 | — | — | -115.8%#14 | — | -536.2%#14 | — | — | -86.3%#15 | — |
| ANVS | $72M#6 | — | — | — | — | -17.3%#7 | — | — | — | — | -27.6%#9 | — |
| MNOV | $71M#7 | — | 1.9x#8 | 172.4x#4 | — | 8.6%#5 | -3242.5%#5 | 32.2%#2 | — | — | 4.0%#3 | — |
| CTOR | $69M#9 | — | 1.7x#7 | — | — | -17.1%#6 | — | -61.3%#7 | — | — | -62.9%#12 | — |
| PLRX | $69M#10 | — | 0.5x#1 | — | — | -29.0%#9 | — | 101.6%#1 | — | — | -33.7%#10 | — |
| ELTX | $69M#11 | — | 8.7x#11 | 29.9x#2 | -91.9%#3 | 23.8%#3 | -1639.0%#3 | -498.6%#13 | — | — | -74.7%#14 | — |
| XBIT | $69M#12 | — | 0.5x#2 | — | -100.0%#4 | -18.2%#8 | — | -35.5%#5 | — | — | -25.2%#7 | — |
| TENX | $68M#13 | — | 0.6x#3 | — | — | -198.9%#15 | — | -46.3%#6 | — | — | -69.5%#13 | — |
| NMAD | $68M#14 | — | 2.8x#9 | 338.1x#5 | — | -69.5%#13 | -2553.8%#4 | -25.4%#4 | — | — | 0.4%#4 | — |
| PMVP | $67M#15 | — | 0.9x#4 | — | — | -32.0%#10 | — | -108.7%#10 | — | — | -16.1%#6 | — |
| BOLD | $65M#16 | — | 1.0x#5 | — | — | 11.0%#4 | — | -88.2%#8 | — | — | 149.8%#1 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议